Novartis AG News Headlines

NVS 
$84.56
*  
0.11
 negative 
0.13%
Get NVS Alerts
*Delayed - data as of Apr. 21, 2014 10:52 ET 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

An Attractive European ETF For Intrepid Investors
10/29/2013 3:58:22 PM - SeekingAlpha

Can Teva Survive Its Cash Cow Loss?
10/23/2013 3:05:00 PM - Seeking Alpha

Novartis Misses Estimates, Guidance Upped - Analyst Blog
10/23/2013 11:50:01 AM - Zacks.com

Cubist Pharma Misses on Earnings and Revenues in Q3 - Analyst Blog
10/23/2013 11:07:45 AM - Zacks.com

Another Earnings and Rev Beat from Amgen - Analyst Blog
10/23/2013 11:07:35 AM - Zacks.com

ARIAD Scraps Iclusig Study, Shares Fall - Analyst Blog
10/22/2013 5:07:22 PM - Zacks.com

Healthcare Stocks Adding to Early Gains; Catalyst Pharma Surging Following Insider Buying
10/22/2013 2:48:28 PM - MT Newswires

Q2 Earnings Miss by PetMed - Analyst Blog
10/22/2013 11:40:01 AM - Zacks.com

Novartis Sales Benefit as Generic Launch Postponed
10/22/2013 10:30:00 AM - Fox Business

Pre-Market Earnings Report for October 22, 2013 : UTX, DD, EMC, LMT, KMB, FCX, ITW, TRV, STT, RAI, NVS, ARMH
10/21/2013 4:00:05 PM - NASDAQ.com News

Roche: Impact Of Rituxan Patent Expiration In Europe
10/21/2013 11:57:00 AM - Seeking Alpha

2 Global Income Stocks To Hedge Against The Dollar
10/21/2013 4:29:00 AM - Seeking Alpha

Week Ahead: Finally, the Jobs Report
10/18/2013 4:03:00 PM - Fox Business

GlaxoSmithKline: Why This Drug Manufacturer Belongs In Everybody's Portfolio
10/18/2013 11:02:00 AM - Seeking Alpha

Pipeline Progress at Omeros - Analyst Blog
10/17/2013 4:07:02 PM - Zacks.com

Near-Term Catalyst Could Double Enanta's Market Cap
10/17/2013 8:02:00 AM - Seeking Alpha

ImmunoGen in Licensing Deals - Analyst Blog
10/16/2013 5:15:01 PM - Zacks.com

Roche Files sBLA for Xolair - Analyst Blog
10/16/2013 4:47:12 PM - Zacks.com

Insmed's Arikace Makes Progress - Analyst Blog
10/16/2013 4:46:44 PM - Zacks.com

Acadia And Parkinson's Treatment Hopes
10/13/2013 5:54:00 PM - Seeking Alpha

My K.I.S.S. Dividend Portfolio 3rd Quarter Update
10/12/2013 7:00:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Flat to Higher; Immunogen up 6% on Licensing to Novartis
10/11/2013 8:07:36 AM - MT Newswires

Sector Update: Healthcare
10/11/2013 8:05:20 AM - MT Newswires

Ariad Shares Slip on Clinical Hold - Analyst Blog
10/10/2013 3:10:01 PM - Zacks.com

XOMA: A Hidden Gem In The Crowded Biotech Sector
10/10/2013 2:07:00 PM - Seeking Alpha